在三级儿科重症监护病房的治疗性血:一个10年的单中心经验
Abdullah Akkuş1, Ahmet Osman Kılıç1, Nefise Betül Ercan2
1Department of Pediatrics, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
概括
治疗性等离子酶 (TP) 是在儿科重症监护室 (PICU) 关键病症儿童的重要支持疗法. 早期启动TP可能会在诸如败血症休克和MIS-C.等疾病中拯救生命.
科学领域:
- 儿科重症监护医学 儿科重症监护医学
- 身体以外的治疗方法
背景情况:
- 治疗性等离子体合成 (TP) 是一种用于治疗各种疾病的体外治疗方法.
- 它在儿科重症监护室 (PICU) 的应用需要进一步研究.
研究的目的:
- 评估在儿科重症监护病房中治疗性血合成的利用和结果.
- 为了确定与重症儿童中TP相关的常见症状,并发症和死亡率.
主要方法:
- 在2013年至2023年期间接受TP的儿科患者的回顾性研究.
- 这些数据是从接受 PICU 治疗的患者的医疗记录中收集的.
主要成果:
- 72名儿童接受了TP;常见的征兆是败血症休克和儿童多系统炎症综合征 (MIS-C).
- 中位数的TP会议是2,中位数的PRISM III得分是14.5.
- 死亡率为44.4%,并发症包括血栓形成在5.6%.
结论:
- 治疗性等离子体结合作为关键的支持性疗法,危重病儿科患者.
- 早期启动TP,以适当的指示为指导,可以提高存活率.
相关概念视频
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
176
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
176
Continuous Renal Replacement Therapy
851
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
851
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Venous Thrombosis III: Interprofessional Care
280
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Pharmacokinetics in Pediatric Patients: Drug Distribution
254
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
254
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
328
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
328


